{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:45:32Z","timestamp":1759729532385,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH382"],"award-info":[{"award-number":["ZR2020MH382"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Program of Shandong Natural Science Foundation","award":["ZR2015HQ030"],"award-info":[{"award-number":["ZR2015HQ030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cryptosporidiosis is a worldwide zoonotic disease. Oxymatrine, an alkaloid extracted and isolated from the plant bitter ginseng, has been reported to have therapeutic effects on cryptosporidiosis. However, the underlying mechanism of its action remains unclear. In this study, we utilized network pharmacology and experimental validation to investigate the mechanism of oxymatrine in the treatment of cryptosporidiosis. First, the potential targets of drugs and diseases were predicted by TCMSP, Gene Cards, and other databases. Following the intersection of drug-disease targets, the DAVID database was used to implement the enrichment analysis of GO functions and KEGG pathways, and then the network diagram of \"intersected target-KEGG\" relationship was constructed. Autodock 4.2.6 software was used to carry out the molecular docking of core targets to drug components. Based on the establishment of a mouse model of cryptosporidiosis, the validity of the targets in the TNF\/NF-\u03baB signaling pathway was confirmed using Western blot analysis and Quantitative Rea-ltime-PCR. A total of 41 intersectional targets of oxymatrine and <jats:italic>Cryptosporidium<\/jats:italic> were generated from the results, and five core targets were screened out by network analysis, including RELA, AKT1, ESR1, TNF, and CASP3. The enrichment analysis showed that oxymatrine could regulate multiple gene targets, mediate TNF, Apoptpsis, IL-17, NF-\u03baB and other signaling pathways. Molecular docking experiments revealed that oxymatrine was tightly bound to core targets with stable conformation. Furthermore, we found through animal experiments that oxymatrine could regulate the mRNA and protein expression of IL-6, NF-\u03baB, and TNF-\u03b1 in the intestinal tissues of post-infected mice through the TNF\/NF-\u03baB signaling pathway. Therefore, it can be concluded that oxymatrine can regulate the inflammatory factors TNF-\u03b1, NF-\u03baB, and IL-6 through the TNF\/NF-\u03baB signaling pathway for the treatment of cryptosporidiosis. This prediction has also been validated by network pharmacology and animal experiments.<\/jats:p>","DOI":"10.1038\/s41598-024-65362-0","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:02:51Z","timestamp":1719223371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanism of oxymatrine in the treatment of cryptosporidiosis through TNF\/NF-\u03baB signaling pathway based on network pharmacology and experimental validation"],"prefix":"10.1038","volume":"14","author":[{"given":"Xiaoning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"65362_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.575881","volume":"7","author":"LJ Robertson","year":"2020","unstructured":"Robertson, L. J., Johansen, \u00d8. H., Kifleyohannes, T., Efunshile, A. M. & Terefe, G. Cryptosporidium infections in Africa-How important is zoonotic transmission? A review of the evidence. Front Vet Sci 7, 575881 (2020).","journal-title":"Front Vet Sci"},{"key":"65362_CR2","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1017\/S0031182014001085","volume":"141","author":"U Ryan","year":"2014","unstructured":"Ryan, U., Fayer, R. & Xiao, L. Cryptosporidium species in humans and animals: current understanding and research needs. Parasitology 141, 1667\u20131685 (2014).","journal-title":"Parasitology"},{"key":"65362_CR3","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1016\/S2214-109X(18)30283-3","volume":"6","author":"IA Khalil","year":"2018","unstructured":"Khalil, I. A. et al. Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study. Lancet Glob Health 6, e758\u2013e768 (2018).","journal-title":"Lancet Glob Health"},{"key":"65362_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.vetpar.2012.06.033","volume":"190","author":"VF Del Coco","year":"2012","unstructured":"Del Coco, V. F. et al. Experimental infection with Cryptosporidium parvum IIaA21G1R1 subtype in immunosuppressed mice. Vet. Parasitol. 190, 411\u2013417 (2012).","journal-title":"Vet. Parasitol."},{"key":"65362_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exppara.2017.07.010","volume":"181","author":"N Madbouly Taha","year":"2017","unstructured":"Madbouly Taha, N. & Yousof, S. A. Atorvastatin repurposing for the treatment of cryptosporidiosis in\u00a0experimentally immunosuppressed mice. Exp. Parasitol. 181, 57\u201369 (2017).","journal-title":"Exp. Parasitol."},{"key":"65362_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/14787210.2018.1500457","volume":"16","author":"MA Chavez","year":"2018","unstructured":"Chavez, M. A. & White, A. C. Novel treatment strategies and drugs in development for cryptosporidiosis. Exp. Rev. Anti Infect. Ther. 16, 655\u2013661 (2018).","journal-title":"Exp. Rev. Anti Infect. Ther."},{"issue":"6","key":"65362_CR7","first-page":"477","volume":"31","author":"D Wang","year":"2013","unstructured":"Wang, D. & Zhang, Y. Y. Therapeutic efficacy of allitridin and azithromycin on Cryptosporidium infection in mice. Zhongguo ji Sheng Chong xue yu ji Sheng Chong Bing za zhi. Chinese J. Parasitol. Parasitic Dis. 31(6), 477\u2013479 (2013).","journal-title":"Chinese J. Parasitol. Parasitic Dis."},{"key":"65362_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpddr.2015.09.002","volume":"5","author":"M-Z Huang","year":"2015","unstructured":"Huang, M.-Z. et al. Therapeutic effects of acetylspiramycin and garlicin on cryptosporidiosis among drug users. Int. J. Parasitol. Drugs Drug Resist. 5, 185\u2013190 (2015).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"65362_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117513","volume":"249","author":"FJ Mocayar Mar\u00f3n","year":"2020","unstructured":"Mocayar Mar\u00f3n, F. J., Camargo, A. B. & Manucha, W. Allicin pharmacology: common molecular mechanisms against neuroinflammation and cardiovascular diseases. Life Sci. 249, 117513 (2020).","journal-title":"Life Sci."},{"issue":"4","key":"65362_CR10","first-page":"275","volume":"31","author":"R Ji","year":"2013","unstructured":"Ji, R., Cui, W., Liang, R. W., Guan, Z. Y. & Li, R. F. Protective effect of radix sophorae flavescentis mixture on intestinal mucosa in mice infected with Cryptosporidium parvum. Zhongguo ji Sheng Chong xue yu ji Sheng Chong Bing za zhi. Chinese J. Parasitol. Parasitic Dis. 31(4), 275\u2013279 (2013).","journal-title":"Chinese J. Parasitol. Parasitic Dis."},{"key":"65362_CR11","first-page":"30","volume":"3","author":"XL Zhang","year":"2013","unstructured":"Zhang, X. L. et al. Regulation Of Astragalus and its polysaccharide on the local mucous membrane immune of Cryptosporidium-infected mice. China Med. Pharm. 3, 30\u201332 (2013).","journal-title":"China Med. Pharm."},{"key":"65362_CR12","doi-asserted-by":"publisher","first-page":"205873841878163","DOI":"10.1177\/2058738418781634","volume":"32","author":"Y Huang","year":"2018","unstructured":"Huang, Y. et al. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2\/STAT3 pathway. Int. J. Immunopathol. Pharmacol. 32, 2058738418781634 (2018).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"65362_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119893","volume":"284","author":"YY Jung","year":"2021","unstructured":"Jung, Y. Y. et al. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells. Life Sci. 284, 119893 (2021).","journal-title":"Life Sci."},{"key":"65362_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.intimp.2016.04.040","volume":"36","author":"H-W Zhao","year":"2016","unstructured":"Zhao, H.-W. et al. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-\u03b21 signaling pathways. Int. Immunopharmacol. 36, 249\u2013255 (2016).","journal-title":"Int. Immunopharmacol."},{"key":"65362_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.apsb.2017.02.005","volume":"7","author":"X Sang","year":"2017","unstructured":"Sang, X. et al. T cell\u2013associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model. Acta Pharm Sin. B 7, 311\u2013318 (2017).","journal-title":"Acta Pharm Sin. B"},{"key":"65362_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.intimp.2017.12.006","volume":"55","author":"J Liang","year":"2018","unstructured":"Liang, J. et al. Oxymatrine prevents synovial inflammation and migration via blocking NF-\u03baB activation in rheumatoid fibroblast-like synoviocytes. Int. Immunopharmacol. 55, 105\u2013111 (2018).","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"65362_CR17","first-page":"295","volume":"30","author":"JI Rui","year":"2018","unstructured":"Rui, J. I., Zhi-Yu, G. U., Rui-Wen, L. I., Feng-Ling, Y. I. & Rui-Fang, L. I. Effect of Cryptosporidium parvum infection on Toll-like receptors of intestinal mucosa in mice. Chinese J. Schistosomiasis Control 30(3), 295 (2018).","journal-title":"Chinese J. Schistosomiasis Control"},{"key":"65362_CR18","first-page":"1364","volume":"42","author":"BB Ye","year":"2022","unstructured":"Ye, B. B., Lin, C., Wang, X. N., Chang, Z. H. & Li, L. F. Study on the mechanism of oxymatrine in the treatment of osteoarthritis by using network pharmacoiogy and moiecuiar docking technoiogy. Henan Traditional Chinese Med. 42, 1364\u20131369 (2022).","journal-title":"Henan Traditional Chinese Med."},{"key":"65362_CR19","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00436-012-3030-7","volume":"111","author":"F Chen","year":"2012","unstructured":"Chen, F. & Huang, K. Effects of the Chinese medicine matrine on experimental C. parvum infection in BALB\/c mice and MDBK cells. Parasitol. Res. 111, 1827\u20131832 (2012).","journal-title":"Parasitol. Res."},{"key":"65362_CR20","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2147\/IJN.S289515","volume":"16","author":"J Hu","year":"2021","unstructured":"Hu, J. et al. Protective effects of radix sophorae flavescentis carbonisata-based carbon dots against ethanol-induced acute gastric ulcer in rats: anti-inflammatory and antioxidant activities. Int. J. Nanomed. 16, 2461\u20132475 (2021).","journal-title":"Int. J. Nanomed."},{"key":"65362_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/13880209.2020.1719165","volume":"58","author":"J Jiang","year":"2020","unstructured":"Jiang, J. & Wang, G. Matrine protects PC12 cells from lipopolysaccharide-evoked inflammatory injury via upregulation of miR-9. Pharm. Biol. 58, 314\u2013320 (2020).","journal-title":"Pharm. Biol."},{"key":"65362_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3748\/wjg.v20.i1.64","volume":"20","author":"J Pedersen","year":"2014","unstructured":"Pedersen, J., Coskun, M., Soendergaard, C., Salem, M. & Nielsen, O. H. Inflammatory pathways of importance for management of inflammatory bowel disease. World J. Gastroenterol. 20, 64\u201377 (2014).","journal-title":"World J. Gastroenterol."},{"key":"65362_CR23","doi-asserted-by":"publisher","first-page":"13815","DOI":"10.1080\/07391102.2023.2196692","volume":"41","author":"P Agnihotri","year":"2023","unstructured":"Agnihotri, P. et al. Anti-inflammatory potential of selective small compounds by targeting TNF-\u03b1 & NF-\u03baB signaling: a comprehensive molecular docking and simulation study. J. Biomol. Struct. Dyn. 41, 13815\u201313828 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"65362_CR24","first-page":"597","volume":"13","author":"M Meshkat","year":"2022","unstructured":"Meshkat, M., Shemshadi, B. & Amini, K. The profile of inflammatory factors in dairy calves with Cryptosporidium infection. Vet. Res. Forum 13, 597\u2013601 (2022).","journal-title":"Vet. Res. Forum"},{"key":"65362_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/biomedicines8100423","volume":"8","author":"EK Elmahallawy","year":"2020","unstructured":"Elmahallawy, E. K. et al. S-Methylcysteine (SMC) ameliorates intestinal, hepatic, and splenic damage induced by cryptosporidium parvum infection via targeting inflammatory modulators and oxidative stress in swiss albino mice. Biomedicines 8, 423 (2020).","journal-title":"Biomedicines"},{"key":"65362_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/2049-632X.12078","volume":"70","author":"G Perez-Cordon","year":"2014","unstructured":"Perez-Cordon, G. et al. Interaction of Cryptosporidium parvum with mouse dendritic cells leads to their activation and parasite transportation to mesenteric lymph nodes. Pathog. Dis. 70, 17\u201327 (2014).","journal-title":"Pathog. Dis."},{"key":"65362_CR27","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/cmi.12632","volume":"18","author":"T de Sablet","year":"2016","unstructured":"de Sablet, T. et al. Cryptosporidium parvum increases intestinal permeability through interaction with epithelial cells and IL-1\u03b2 and TNF\u03b1 released by inflammatory monocytes. Cell. Microbiol. 18, 1871\u20131880 (2016).","journal-title":"Cell. Microbiol."},{"issue":"18","key":"65362_CR28","doi-asserted-by":"publisher","first-page":"30165","DOI":"10.1016\/j.jdermsci.2018.04.009","volume":"S0923\u20131811","author":"X Xu","year":"2018","unstructured":"Xu, X. et al. Anti-pruritic and anti-inflammatory effects of oxymatrine in a mouse model of allergic contact dermatitis. J. Dermatol. Sci. S0923\u20131811(18), 30165\u201330168. https:\/\/doi.org\/10.1016\/j.jdermsci.2018.04.009 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"65362_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109612","volume":"115","author":"M Liu","year":"2023","unstructured":"Liu, M. et al. Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR\/NF-\u03baB pathway. Int. Immunopharmacol. 115, 109612 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"65362_CR30","doi-asserted-by":"publisher","first-page":"01067","DOI":"10.3389\/fphar.2020.01067","volume":"16","author":"L You","year":"2020","unstructured":"You, L. et al. A systematic review of the pharmacology, toxicology and pharmacokinetics of matrine. Front. Pharmacol. 16(11), 01067 (2020).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65362-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T13:04:22Z","timestamp":1719493462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65362-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["65362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-65362-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14469"}}